Spirometers for measuring exhaled air volume have been used in clinical practice for many years now, but the technology has been underutilized due to technology costs limiting accessibility and devices not meeting industry recommendations. Getting it into the hands of patients and making the process easy, convenient, and clinically useful can help reduce exacerbations, predict disease progression, and reduce the usage of steroids. My Spirometer is a new company that developed new technology for making lung function testing something that can be adopted for wider at-home use by COPD and asthma patients to help control their conditions.
The firm developed a smart spirometer that can accurately measure lung function (FEV1, FVC, FEV1/FVC, FEFmax), transfer that information to a smartphone and onto the physician.
The MySpirometer is not yet available on the market, but the firm has already completed waveform testing with the American Thoracic Society and European Respiratory Society and is starting to move the product toward commercialization.
The device is designed to be very easy to use, by both adults and children, while allowing respiratory care professionals to review results from multiple patients through a HIPAA-compliant platform.
While there are other connected spirometers coming to market, the folks at My Spirometer believe that their focus on an accurate and affordable”minimum viable product” will greatly improve lung function testing for post-surgical scenarios, cystic fibrosis, asthma, and pediatric asthma.
Product page: MySpirometer…